Back to preview
  • Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births (Line chart)
  • Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births (Bar chart)
  • Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births (Boxplot chart)
Data set notes
European Health for All database

Indicators: 618
Updated: 24 January 2024

The following abbreviations are used in the indicator titles:
•    SDR: age-standardized death rates (see HFA-DB user manual/Technical notes, page 13, for details)
•    FTE: full-time equivalent
•    PP: physical persons
•    PPP$: purchasing power parities expressed in US $, an internationally comparable scale reflecting the relative domestic purchasing powers of currencies.

Indicator notes
Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births
Indicator code: E080103.F This indicator shares the definition with the parent indicator \"\".

Maternal deaths, toxaemia pregnancy. ICD-10 codes: O13 - O16, O21
Country/Area notes
No information
General notes

Understanding Maternal Deaths, Gestational Hypertension, and Hyperemesis per 100,000 Live Births

This indicator provides crucial insights into maternal health, specifically focusing on deaths associated with gestational conditions such as pregnancy-induced hypertension and hyperemesis. These conditions can significantly impact maternal morbidity and mortality rates and are a key focus of healthcare interventions. By monitoring these rates, healthcare providers and policymakers can better understand the effectiveness of current healthcare strategies and the areas needing urgent attention to improve maternal health outcomes and ensure safer pregnancies.

How to Calculate Maternal Deaths, Gestational Hypertension, and Hyperemesis per 100,000 Live Births

The calculation of this maternal health indicator involves several critical steps. It starts by identifying all maternal deaths that are directly linked to gestational hypertension and hyperemesis within a given year. These figures are then divided by the total number of live births in the same period, multiplied by 100,000 to standardize the rate. This method allows for consistent comparisons over time and across different regions, providing a clear picture of how these specific conditions affect maternal health on a broader scale.

The Importance of Tracking Maternal Deaths, Gestational Hypertension, and Hyperemesis

Monitoring these specific maternal health indicators is vital for several reasons. Firstly, it helps health services to identify trends and potential outbreaks of these conditions, facilitating timely and effective interventions. Secondly, it provides valuable data for evaluating the success of existing healthcare policies and practices, guiding future improvements. Lastly, understanding these metrics helps in advocating for necessary resources and support systems to protect maternal health, ultimately leading to better health outcomes for mothers and their babies.

Strengths and Limitations of the Maternal Deaths, Gestational Hypertension, and Hyperemesis Indicator

While this indicator is a valuable tool for assessing maternal health, it comes with its own set of strengths and limitations.

Strengths

The primary strength of this indicator lies in its ability to provide targeted data on specific conditions affecting maternal health. This specificity allows for more focused research and healthcare interventions, potentially leading to significant improvements in maternal care. Additionally, the standardized calculation method facilitates reliable comparisons over time and across different geographical areas, enhancing global health monitoring and collaborative efforts to improve maternal health outcomes.

Limitations

However, there are several limitations to consider. The accuracy of this indicator heavily depends on the quality of data collection regarding maternal deaths and live births. In regions with less developed healthcare reporting systems, data may be incomplete or inaccurate, leading to potential misrepresentations of the true scale of the problem. Furthermore, this indicator does not account for all possible complications related to pregnancy, such as other pre-existing conditions that could also contribute to maternal deaths. This can limit the comprehensiveness of the insights provided by this metric.

Moreover, the focus on only two specific conditions might overshadow other critical aspects of maternal health that also require attention and resources. Therefore, while this indicator is a crucial part of maternal health monitoring, it should be used in conjunction with other metrics for a more holistic approach to understanding and improving maternal health outcomes.